What do we do?
We are a Spanish pharmaceutical company engaged in the research and development, manufacturing and marketing of small molecules and biological medical products.
We likewise use our sales channels to market a number of licensed pharmaceutical products, imaging contrast agents and other products for hospital use, as well as OTC pharmaceuticals.
All of this is carried out through our specialized sales team formed by more than 260 people who promote the products with specialized medical professionals and in hospitals and pharmacies.
What will you do?
Realizar revisión en planta de fabricación de las actividades calendarizadas en el departamento para comprobar su correcta ejecución en rutina, y posibles mejoras en el CCS. Actividades relacionadas con proceso de fabricación de inyectables tales como:
Procesos de vestimenta en distintos tipos de areas clasificadas,
Proceso y flujo de desinfección de materiales
Prácticas asépticas de las operaciones según clasificación y actividad
Ejecución de walkthrough en planta de fabricaicón, utilities y laboratorio
Detección de posibles incumplimientos procedimentales y7o actividades mejorables.
Puesta en común con las áreas relacionadas y propuestas de mecanismos de mejora.
Your contract type will be:
Temporary (duración determinada)
The required education for the job is:
Technical Diploma: Biology
The experience for this job is:
From 1 to 2 years
Laboratorios Farmacéuticos ROVI, S.A. is a chemical and pharmaceutical company incorporated in Madrid in 1946 and its activities concentrate on its own pharmaceutical products, manufacturing for third parties and distribution of other products for which it holds a licence from other laboratories devoting all its efforts to the satisfaction of its internal and external clients for the promotion of health within Society.
ROVI´s dedication and its strategy of encouraging the international trade, has led to extend Bemiparin presence, whether in pre-registration, registration or marketing stage, to a total of 88 countries thanks to the strategic alliances established with our 22 international partners.
